160 related articles for article (PubMed ID: 36537722)
1. UHRF1 plays an oncogenic role in small cell lung cancer.
Hou J; Li W; Zhang S; Tan D; Lv K; Zhu Y; Hou Y; Guo H; Jiang L
Mol Carcinog; 2023 Mar; 62(3):385-397. PubMed ID: 36537722
[TBL] [Abstract][Full Text] [Related]
2. UHRF1 inhibition mitigates vascular endothelial cell injury and ameliorates atherosclerosis in mice via regulating the SMAD7/YAP1 axis.
Li W; Bai P; Li W
Mol Immunol; 2024 Jun; 170():119-130. PubMed ID: 38657333
[TBL] [Abstract][Full Text] [Related]
3. YAP1 promotes multidrug resistance of small cell lung cancer by CD74-related signaling pathways.
Song Y; Sun Y; Lei Y; Yang K; Tang R
Cancer Med; 2020 Jan; 9(1):259-268. PubMed ID: 31692299
[TBL] [Abstract][Full Text] [Related]
4. Circ ubiquitin-like-containing plant homeodomain and RING finger domains protein 1 increases the stability of G9a and ubiquitin-like-containing plant homeodomain and RING finger domains protein 1 messenger RNA through recruiting eukaryotic translation initiation factor 4A3, transcriptionally inhibiting PDZ and homeobox protein domain protein 1, and promotes the metastasis of hepatocellular carcinoma.
Huang X; Zhou LZ; Feng WJ; Liu YQ; Chen M; Tang LY; Gan ZY; Zhang P
J Gastroenterol Hepatol; 2024 Mar; 39(3):596-607. PubMed ID: 38059880
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
Xu L; Xu F; Kong Q; Yang T; Tan D; Zhang X; Li N; Zhao S; Zhao J; Li M
Mol Carcinog; 2020 Aug; 59(8):967-979. PubMed ID: 32424979
[TBL] [Abstract][Full Text] [Related]
6. UHRF1 is regulated by miR-124-3p and promotes cell proliferation in intrahepatic cholangiocarcinoma.
Zhu M; Wei C; Lin J; Dong S; Gao D; Chen J; Zhao Y; Liu B
J Cell Physiol; 2019 Nov; 234(11):19875-19885. PubMed ID: 30989656
[TBL] [Abstract][Full Text] [Related]
7. Regulation of UHRF1 acetylation by TIP60 is important for colon cancer cell proliferation.
Hong YJ; Park J; Hahm JY; Kim SH; Lee DH; Park KS; Seo SB
Genes Genomics; 2022 Nov; 44(11):1353-1361. PubMed ID: 35951156
[TBL] [Abstract][Full Text] [Related]
8.
Goto D; Komeda K; Uwatoko N; Nakashima M; Koike M; Kawai K; Kodama Y; Miyazawa A; Tanaka I; Hase T; Morise M; Hasegawa Y; Kawabe T; Sato M
Cancer Invest; 2020 Apr; 38(4):240-249. PubMed ID: 32212938
[TBL] [Abstract][Full Text] [Related]
9. WDR79 mediates the proliferation of non-small cell lung cancer cells by regulating the stability of UHRF1.
Chen J; Sheng X; Ma H; Tang Z; Yang C; Cao L; Sun Y; Deng T; Feng P; Hu B; Wei D; Liu J; Xiong W; Ye M
J Cell Mol Med; 2018 May; 22(5):2856-2864. PubMed ID: 29516630
[TBL] [Abstract][Full Text] [Related]
10. Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies.
Ng J; Cai L; Girard L; Prall OWJ; Rajan N; Khoo C; Batrouney A; Byrne DJ; Boyd DK; Kersbergen AJ; Christie M; Minna JD; Burr ML; Sutherland KD
Clin Cancer Res; 2024 May; 30(9):1846-1858. PubMed ID: 38180245
[TBL] [Abstract][Full Text] [Related]
11.
Hu B; Xian Z; Zou Q; Zhang D; Su D; Yao J; Ren D
Cancer Biother Radiopharm; 2021 Feb; 36(1):45-57. PubMed ID: 32379550
[No Abstract] [Full Text] [Related]
12. Loss of YAP1 defines neuroendocrine differentiation of lung tumors.
Ito T; Matsubara D; Tanaka I; Makiya K; Tanei ZI; Kumagai Y; Shiu SJ; Nakaoka HJ; Ishikawa S; Isagawa T; Morikawa T; Shinozaki-Ushiku A; Goto Y; Nakano T; Tsuchiya T; Tsubochi H; Komura D; Aburatani H; Dobashi Y; Nakajima J; Endo S; Fukayama M; Sekido Y; Niki T; Murakami Y
Cancer Sci; 2016 Oct; 107(10):1527-1538. PubMed ID: 27418196
[TBL] [Abstract][Full Text] [Related]
13. MiR-9-1 Suppresses Cell Proliferation and Promotes Apoptosis by Targeting UHRF1 in Lung Cancer.
Jia CY; Xiang W; Liu JB; Jiang GX; Sun F; Wu JJ; Yang XL; Xin R; Shi Y; Zhang DD; Li W; Zuberi Z; Zhang J; Lu GX; Wang HM; Wang PY; Yu F; Lv ZW; Ma YS; Fu D
Technol Cancer Res Treat; 2021; 20():15330338211041191. PubMed ID: 34520284
[TBL] [Abstract][Full Text] [Related]
14. UHRF1 predicts poor prognosis by triggering cell cycle in lung adenocarcinoma.
Tu Z; Deng X; Hou S; Feng A; Zhang Q
J Cell Mol Med; 2020 Jul; 24(14):8069-8077. PubMed ID: 32495469
[TBL] [Abstract][Full Text] [Related]
15. UHRF1 downregulation promotes T follicular helper cell differentiation by increasing BCL6 expression in SLE.
Liu L; Hu L; Yang L; Jia S; Du P; Min X; Wu J; Wu H; Long H; Lu Q; Zhao M
Clin Epigenetics; 2021 Feb; 13(1):31. PubMed ID: 33568199
[TBL] [Abstract][Full Text] [Related]
16. UHRF1 regulates global DNA hypomethylation and is associated with poor prognosis in esophageal squamous cell carcinoma.
Nakamura K; Baba Y; Kosumi K; Harada K; Shigaki H; Miyake K; Kiyozumi Y; Ohuchi M; Kurashige J; Ishimoto T; Iwatsuki M; Sakamoto Y; Yoshida N; Watanabe M; Nakao M; Baba H
Oncotarget; 2016 Sep; 7(36):57821-57831. PubMed ID: 27507047
[TBL] [Abstract][Full Text] [Related]
17. UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma.
Kostyrko K; Román M; Lee AG; Simpson DR; Dinh PT; Leung SG; Marini KD; Kelly MR; Broyde J; Califano A; Jackson PK; Sweet-Cordero EA
Nat Commun; 2023 Jul; 14(1):3966. PubMed ID: 37407562
[TBL] [Abstract][Full Text] [Related]
18. The long non-coding RNA UPAT promotes gastric cancer cell progression via UHRF1.
Liu C; Hao D; Ai M; Zhang Y; Li J; Xu C
Genes Genomics; 2022 Oct; 44(10):1283-1300. PubMed ID: 35294719
[TBL] [Abstract][Full Text] [Related]
19. UHRF1 modulates breast cancer cell growth via estrogen signaling.
Luo G; Li Q; Yu M; Wang T; Zang Y; Liu Z; Niu Z; Yang H; Lai J
Med Oncol; 2022 Jun; 39(8):111. PubMed ID: 35666346
[TBL] [Abstract][Full Text] [Related]
20. Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinoma.
Liu X; Ou H; Xiang L; Li X; Huang Y; Yang D
Oncotarget; 2017 Feb; 8(6):10510-10522. PubMed ID: 28060737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
